Holdings

TCG Crossover Management, LLC

As of Sep 30, 2026, TCG Crossover Management, LLC reported 52 positions worth US$3.29B. Largest: Abivax SA, CG Oncology, Inc. and Amylyx Pharmaceuticals, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Abivax SA3.66MUS$363M−2.34MSep 30, 2026
CG Oncology, Inc.3.67MUS$260Mno changeSep 30, 2026
Amylyx Pharmaceuticals, Inc.6.24MUS$182Mno changeSep 30, 2026
Spyre Therapeutics, Inc.1.9MUS$169Mno changeSep 30, 2026
Tango Therapeutics, Inc.6.77MUS$169M−2.31MSep 30, 2026
Zai Lab Ltd.6.23MUS$164M+91,454Sep 30, 2026
Immunovant, Inc.4.46MUS$151Mno changeSep 30, 2026
Dianthus Therapeutics, Inc.1.68MUS$148Mno changeSep 30, 2026
Kodiak Sciences Inc1.45MUS$137Mno changeSep 30, 2026
Vor Biopharma Inc.5.67MUS$108Mno changeSep 30, 2026